There is compelling evidence that serotonin system dysfunction is associated with certain behavioral disorders, such as suicidal behavior and impulsive aggression. A functional polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) was recently identified and the presence of the short allele found to be associated with a lower level of expression of the gene, lower levels of 5-HT uptake, suicidal behavior and anxiety-related traits. We genotyped 51 West European Caucasians who had made violent suicide attempts and 139 controls of the same ethnic origin, with no history of suicidal behavior. The frequencies of the S allele and the SS genotype were significantly higher in the violent suicide attempters than in the controls. The odds ratio for the SS genotype vs the LL genotype was 3.63 (95% CI (1.27-10.40)). This suggests that a change in expression of the gene encoding the 5-HT transporter may be involved in violent suicidal behavior. Molecular Psychiatry (2001) 6, 338-341. Since the seminal studies by Asberg and collaborators in the mid 1970s, 1 most studies have shown that impulsive aggression and suicidal behavior are correlated with low levels of 5-HT transmission.
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Since the seminal studies by Asberg and collaborators in the mid 1970s, 1 most studies have shown that impulsive aggression and suicidal behavior are correlated with low levels of 5-HT transmission. 2 This association is stronger for more severe phenotypes: lethal and/or violent suicidal behavior and violent aggressive behavior. [3] [4] [5] The magnitude and duration of serotonergic activity is believed to be regulated mainly by the human serotonin transporter (5-HTT), which controls the uptake of serotonin from the synaptic junction. 6, 7 The human 5-HTT is in a presynaptic location and Lesch et al 7 have demonstrated that it is identical in platelets and in the brain. Conflicting results have been obtained in studies of the platelet 5-HT transporter in individuals with suicidal behavior. Some studies have shown a decrease in the number of 5-HT transporter recognition sites in such individuals, as shown by the radiolabeled ligand-binding technique, and in the amount of 5-HT transporter protein, as shown by 5-HT uptake measurements. 8, 9 Despite differences in the results obtained, probably due to differences in the ligands used, studies of radioligand binding in the brainstem of individuals who have committed suicide and in platelets have provided evidence that there is a negative association between serotonin dysfunction and impulsive aggression and violent or suicidal behavior. [8] [9] [10] [11] Coccaro et al 11 studied patients with personality disorders and found a negative correlation between aggression and tritiated paroxetine binding to platelet serotonin transporter sites. Roy 9 recently reported that the affinity of the serotonin uptake protein for serotonin is lower in depressed patients displaying suicidal behavior than in depressed patients who have never attempted suicide and in controls. This lower affinity for serotonin was also found to have predictive value for subsequent suicide attempts and suicides during a 5-year follow-up period.
Pharmacological studies have also provided evidence that the serotonin transporter is involved in modulating aggressive behavior, as shown by the consistent response of patients to 5-HT reuptake inhibitors. Several recent controlled trials have reported that specific serotonin reuptake inhibitors (SSRI) are effective at reducing the recurrence of suicide attempts and decreasing impulsive aggression traits in subjects with and without personality disorders. 12, 13 These main effects were independent of an antidepressant effect.
Neuroimaging techniques are a promising new tool for exploring and locating neurotransmitter abnormalities in the brain. In a single-photon emission tomography study, Tiihonen et al 14 compared impulsive, alcoholic, violent offenders, normal control subjects and nonviolent alcoholic control subjects and found that impulsive aggression was associated with a decrease in 5-HT transporter density.
The human 5-HTT is encoded by a single gene (SLC6A4), located on 17q12. 6, 7 A biallelic functional polymorphism in the 5Ј regulatory promoter region (termed 5-HTTLPR), involving two alleles, corresponding to a 44-bp insertion (L-allele) or deletion (S-allele), regulates transcription of the 5-HTT gene. 15 The S promoter is less active than the L promoter, resulting in lower levels of 5-HT uptake. 6, 16 The shorter allele has been found to be associated with affective disorders 17 and with anxiety-related personality traits, such as harm avoidance and neuroticism. 6, 18 Recent studies have investigated the possible association of the 5-HTTLPR with suicidal behavior. [19] [20] [21] The data obtained from studies involving small samples and poorly defined phenotypes of suicidal behavior have been inconclusive. 19, 20 Bondy et al 21 recently reported a higher frequency of the S allele in 58 individuals with unknown psychiatric diagnoses who used violent means to commit suicide, than in 110 healthy controls. This suggests that 5-HTTLPR may be one component of genetic susceptibility to suicidal behavior. Indeed, several epidemiological genetics studies have demonstrated specific genetic susceptibility to suicidal behavior independently of psychiatric disorders, but the genes responsible have not been identified. 22 As part of an ongoing genetic study of suicide attempt, we investigated the same 5-HTTLPR polymorphism in 51 suicide attempters who used violent methods similar to those used by the suicide victims in the study of Bondy et al, 21 and 139 controls of West European Caucasian origin.
Genotype frequencies were in Hardy-Weinberg equilibrium (Table 1 ). Allele and genotype frequencies in the control group were similar to those reported in previous studies in Caucasian populations. 6, 20, 21 The frequency of the S allele was significantly higher in the 51 violent suicide attempters than in individuals who had not attempted suicide (56% vs 42%, 2 = 5.42, df = 1, P = 0.02). The smaller proportion of LL homozygotes among the violent suicide attempters was compensated by significantly higher proportions of the SL and SS genotypes ( 2 = 6.47, df = 2, P = 0.04). These allele and genotype frequencies are very similar to those reported by Bondy et al 21 in suicide victims. Using bearers of the L allele as the reference group, the odds ratios (ORs) for the S allele, and the SS genotype were 1.72 (95% CI (1.09-2.71)) and 3.63 (95% CI (1.27-10.40)) respectively.
As most suicide attempters have a history of major mood disorder (MMD), this difference may be due to MMD rather than to the suicide attempt itself. We therefore compared non suicidal attempters with and without a history of MMD. No significant difference was observed between these two groups (the S allele and the SS genotype were, if anything, less frequent in the MMD subgroup; see Table 1 ). In contrast, the frequencies of the S allele and the SS genotype were 21 The difference between these two studies is the population used: Bondy et al 21 studied suicide victims whereas we studied individuals who had attempted suicide but had not succeeded. However, in both studies, similar violent methods were used, suggesting that the reported association has more to do with the violence of the act than with its lethality. This is consistent with the findings of early biochemical studies by Asberg and collaborators. 1 A similar association with the S 5-HTTLPR allele, has been reported in a different, but related phenotype (early-onset alcoholism associated with violent behavior). 23 These genetic data are consistent with the results of biochemical and neuroimaging studies, suggesting a correlation between low 5-HT uptake activity and violent behavior, including violent suicidal behavior. 9, 11, 14 We found no difference between non suicide attempters with and without a history of MMD, suggesting that MMD itself cannot account for the difference observed between suicide attempters and controls. However, the highest ORs were obtained for comparisons of violent suicide attempters with a history of MMD to individuals with a history of MMD who had not attempted suicide. We therefore suggest that the low activity allele of the 5-HTTLPR is associated with a psychobiological trait that is more common in subjects with a history of both MMD and violent suicide attempt.
Similar conclusions were drawn in studies of two other serotonin-related genes: the tryptophan hydroxylase gene and the monoamine A gene. [24] [25] [26] These results are consistent with a multigenic model in which several susceptibility genes each have a small effect, contributing to violent and suicidal behavior. The combination of these specific genetic variants, encoding molecules acting at various steps in serotonin metabolism and signal transduction, may result in the overall low activity of the serotonin system that has repeatedly been shown to be associated with violent and suicidal behavior. The combined study of several serotonin-related genes in large populations, with dimensional personality characterization, is now required to confirm this hypothesis and to identify the psychobiological trait responsible for violent and suicidal behavior.
Methods

Sample
Fifty-one patients (35 men, 16 women; 38.6 ± 13.2 years old) consecutively admitted to our psychiatric departments after a violent suicide attempt gave informed consent and were included in this study. A suicide attempt was defined as intentional self-harm that was not self-mutilatory in nature 8 and required medical evaluation and treatment in an emergency or intensive care unit. Suicide attempts were classified as violent according to the criteria proposed by Asberg et al. 1 Hanging attempts (n = 11), the use of firearms (n = 17), jumping from heights (n = 7), several deep cuts (n = 5), car crash (n = 4), burning (n = 2), gas poisoning (n = 2), drowning (n = 1), electrocution (n = 1), and jumping under a train (n = 1) were considered to be violent attempts; drug overdoses were considered to be nonviolent suicide attempts. For all patients, we investigated whether there was a past history of violent suicide attempt and, if there was, the patient was classified as a violent suicide attempter whatever the nature of the current attempt. All patients were interviewed using a DSM-III-R checklist, by two experienced psychiatrists (MA and PC), and lifetime diagnoses were made according to DSM-III-R criteria. For this study, the axis I diagnoses known to be associated with a high risk of suicidal behavior were investigated: major mood disorders (MMD) (n = 40), schizophrenia (n = 3), alcohol and substance dependence (n = 11).
The 139 individuals who had not attempted suicide (90 men, 49 women; 45.2 ± 13.2 years old) were interviewed by trained psychiatrists with a French version of the Diagnostic Interview for Genetic Studies (DIGS). 27 Subjects with a personal or familial (first degree) history of suicide attempts were excluded from the controls. These individuals are part of an ongoing genetic study of personality traits in blood donors. They were assigned to two subgroups according to the presence (n = 44) or absence (n = 95) of a history of major mood disorder. Both groups of patients and controls were entirely of West European Caucasian origin, to minimize population heterogeneity. The study was approved by the institutional ethics committee and written informed consent was obtained from all subjects.
Laboratory methods
Blood samples (15 ml) were collected into EDTA and genomic DNA was extracted from white blood cells (DNA extraction kit from Amersham-Pharmacia Biotech, Dü bendorf, Switzerland). Polymorphism in the promoter region of the gene was analyzed after amplification of the fragment with the primers: 15 
HTTLPRF
(GGCGTTGCCGCTCTGAATTGC) and HTTLPRR (GAGGGACTGAGCTGGACAACCCAC). PCR was performed with 10 pmoles of the primers, 120 nM DNTP, 80 nM DNTP containing 7-deaza-dGTP instead of DGTP (Roche, Rotkreuz, Switzerland), 5% DMSO (Sigma, Buchs, Switzerland), 1.5 mM MgCl 2 , 1.25 U Eurobio Taq polymerase (Eurobio, Brunschwig, Basel, Switzerland) in a total volume of 25 l. Temperature annealing was 60°C for 30 s and extension was 1 min at 72°C. PCR products (8 l) were subjected to electrophoresis in a 1.4% agarose gel (Eurobio, Brunschwig) in 1 × TBE. After 3 h of electrophoresis at 120 V, the gel was stained with ethidium bromide and viewed under UV. Only two types of allele were observed (short −484 bp, S-allele-and long −528 bp, L-allele-).
Statistical analysis
Allele and genotype distributions for patients and controls were compared using the chi-square test (twotailed). Odds ratios with 95% confidence intervals were calculated using Woolf's method.
